|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 35/76 | |
| A61K 39/00 | |||
| A61K 39/395 | |||
| A61P 35/00 | |||
| C07K 14/475 | |||
| C07K 16/28 | |||
| C12N 15/863 | |||
| A61K 35/768 |
| (11) | Number of the document | 3169340 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15738652.5 |
| Date of filing the European patent application | 2015-07-16 | |
| (97) | Date of publication of the European application | 2017-05-24 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2015/066353 |
| Date | 2015-07-16 |
| (87) | Number | WO 2016/009017 |
| Date | 2016-01-21 |
| (30) | Number | Date | Country code |
| 14306155 | 2014-07-16 | EP |
| (72) |
ZITVOGEL, Laurence, FR
PREVILLE, Xavier, FR
FEND, Laetitia, FR
|
| (73) |
Institut Gustave Roussy,
39, rue Camille Desmoulins, 94800 Villejuif,
FR
TRANSGENE, Parc d`Innovation Boulevard Gonthier d`Andernach, 67400 Illkirch-Graffenstaden, FR |
| (54) | COMBINATION OF ONCOLYTIC VIRUS WITH IMMUNE CHECKPOINT MODULATORS |
| COMBINATION OF ONCOLYTIC VIRUS WITH IMMUNE CHECKPOINT MODULATORS |